DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 050711
The generic ingredient in ZITHROMAX is azithromycin. There are thirty-two drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the azithromycin profile page.
Summary for 050711
Tradename: | ZITHROMAX |
Applicant: | Pfizer |
Ingredient: | azithromycin |
Patents: | 1 |
Therapeutic Class: | Antibacterials |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 050711
Ingredient-type | Macrolides |
Medical Subject Heading (MeSH) Categories for 050711
Suppliers and Packaging for NDA: 050711
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZITHROMAX | azithromycin | TABLET;ORAL | 050711 | NDA | Pfizer Laboratories Div Pfizer Inc | 0069-3060 | N | 0069-3060-86 |
ZITHROMAX | azithromycin | TABLET;ORAL | 050711 | NDA | Pfizer Laboratories Div Pfizer Inc | 0069-3060 | N | 0069-3060-75 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 250MG BASE | ||||
Approval Date: | Jul 18, 1996 | TE: | AB | RLD: | Yes | ||||
Patent: | ➤ Try a Free Trial | Patent Expiration: | Jul 31, 2018 | Product Flag? | Substance Flag? | Y | Delist Request? |
Complete Access Available with Subscription